Viridian Therapeutics Statistics
Total Valuation
VRDN has a market cap or net worth of $1.24 billion. The enterprise value is $629.12 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, before market open.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VRDN has 81.59 million shares outstanding. The number of shares has increased by 47.46% in one year.
| Current Share Class | 81.59M |
| Shares Outstanding | 81.59M |
| Shares Change (YoY) | +47.46% |
| Shares Change (QoQ) | +1.61% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 96.49% |
| Float | 67.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4,114.72 |
| Forward PS | 7,813.50 |
| PB Ratio | 2.99 |
| P/TBV Ratio | 2.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2,083.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.49, with a Debt / Equity ratio of 0.04.
| Current Ratio | 19.49 |
| Quick Ratio | 18.88 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -110.67 |
Financial Efficiency
Return on equity (ROE) is -51.95% and return on invested capital (ROIC) is -34.19%.
| Return on Equity (ROE) | -51.95% |
| Return on Assets (ROA) | -32.62% |
| Return on Invested Capital (ROIC) | -34.19% |
| Return on Capital Employed (ROCE) | -53.73% |
| Revenue Per Employee | $2,112 |
| Profits Per Employee | -$1.70M |
| Employee Count | 143 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.29% in the last 52 weeks. The beta is 0.45, so VRDN's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +15.29% |
| 50-Day Moving Average | 13.96 |
| 200-Day Moving Average | 17.74 |
| Relative Strength Index (RSI) | 58.07 |
| Average Volume (20 Days) | 729,139 |
Short Selling Information
The latest short interest is 11.34 million, so 13.89% of the outstanding shares have been sold short.
| Short Interest | 11.34M |
| Short Previous Month | 10.70M |
| Short % of Shares Out | 13.89% |
| Short % of Float | 16.87% |
| Short Ratio (days to cover) | 14.99 |
Income Statement
In the last 12 months, VRDN had revenue of $302,000 and -$243.10 million in losses. Loss per share was -$3.33.
| Revenue | 302,000 |
| Gross Profit | -237.02M |
| Operating Income | -337.00M |
| Pretax Income | -228.06M |
| Net Income | -243.10M |
| EBITDA | -336.49M |
| EBIT | -337.00M |
| Loss Per Share | -$3.33 |
Full Income StatementBalance Sheet
The company has $636.63 million in cash and $23.11 million in debt, giving a net cash position of $613.53 million or $7.52 per share.
| Cash & Cash Equivalents | 636.63M |
| Total Debt | 23.11M |
| Net Cash | 613.53M |
| Net Cash Per Share | $7.52 |
| Equity (Book Value) | 604.47M |
| Book Value Per Share | 5.09 |
| Working Capital | 623.51M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$279.75 million and capital expenditures -$597,000, giving a free cash flow of -$280.35 million.
| Operating Cash Flow | -279.75M |
| Capital Expenditures | -597,000 |
| Free Cash Flow | -280.35M |
| FCF Per Share | -$3.44 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -111,590.73% |
| Pretax Margin | -102,092.38% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VRDN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -47.46% |
| Shareholder Yield | -47.46% |
| Earnings Yield | -19.56% |
| FCF Yield | -22.56% |
Analyst Forecast
The average price target for VRDN is $38.50, which is 152.79% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $38.50 |
| Price Target Difference | 152.79% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 407.03% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 13, 2020. It was a reverse split with a ratio of 0.0666666:1.
| Last Split Date | Nov 13, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.0666666:1 |
Scores
VRDN has an Altman Z-Score of 10.51.
| Altman Z-Score | 10.51 |
| Piotroski F-Score | n/a |
